Why Your A|c Might Be High Even When Your Diet Is Perfect: The Sleep Apnea Connection

As a functional nutrition practitioner, one of the things I love most about this work is looking outside the box. When a client comes to me with a high A1c but eats well, exercises regularly, and manages stress reasonably well, I don't just shrug and recommend cutting more carbs. I start asking different questions.

One of the most surprising and underappreciated connections I've repeatedly uncovered in clinical practice is the relationship between sleep apnea and blood sugar dysregulation. Time and time again, I've worked with clients who are doing everything "right" nutritionally, yet their A1c remains stubbornly elevated. When we dig deeper and use a continuous glucose monitor (CGM), we often see something striking: glucose spikes at night, during sleep, even when they haven't eaten for hours.

A sleep study frequently reveals the culprit: obstructive sleep apnea (OSA) and intermittent hypoxia, repeated drops in blood oxygen throughout the night.

What Is Sleep Apnea and Why Does It Matter for Blood Sugar?

Obstructive sleep apnea is a condition in which the upper airway repeatedly collapses during sleep, causing brief but significant interruptions in breathing. These episodes, which can occur dozens or even hundreds of times per night, cause blood oxygen levels to drop repeatedly, a phenomenon called intermittent hypoxia.

Most people think of sleep apnea as a snoring problem or a cardiovascular risk factor. Far fewer realize that it is also a powerful driver of metabolic dysfunction, including insulin resistance, elevated fasting glucose, and type 2 diabetes.

The Mechanisms: How Sleep Apnea Dysregulates Blood Sugar

The connection between sleep apnea and blood sugar dysregulation is not coincidental. It operates through several well-documented biological pathways.

1. Intermittent Hypoxia and Cortisol

Every time breathing stops during sleep, the body perceives a threat. The sympathetic nervous system activates, triggering a stress response that releases cortisol and catecholamines (epinephrine and norepinephrine). These stress hormones signal the liver to release glucose into the bloodstream,  a process called hepatic glucose output,  to prepare the body for a perceived emergency.

This is why CGM data in clients with undiagnosed sleep apnea often shows glucose spikes in the middle of the night. The body is essentially experiencing repeated mini-stress responses, each dumping glucose into the bloodstream, even in a fasted state.

Research published in the American Journal of Respiratory and Critical Care Medicine confirmed that intermittent hypoxia directly activates the hypothalamic-pituitary-adrenal (HPA) axis, elevating cortisol and driving nocturnal glucose excursions.¹

2. Insulin Resistance

Chronic intermittent hypoxia impairs insulin signaling at the cellular level. Studies have shown that repeated episodes of oxygen desaturation reduce the sensitivity of peripheral tissues, particularly skeletal muscle and adipose tissue, to insulin. This means that even when insulin is present, glucose cannot be efficiently taken up into cells, leading to chronically elevated blood glucose and compensatory hyperinsulinemia.

A landmark study published in Diabetes Care found that the severity of oxygen desaturation during sleep was independently associated with insulin resistance, even after controlling for obesity, age, and other metabolic risk factors.²

3. Sympathetic Nervous System Activation

Sleep apnea chronically activates the sympathetic nervous system, the "fight or flight" response, even during sleep. Sustained sympathetic activation suppresses insulin secretion from pancreatic beta cells and promotes glucagon release, both of which raise blood glucose. Over time, this chronic activation contributes to beta cell dysfunction and impaired glucose regulation.³

4. Sleep Fragmentation and Circadian Disruption

Beyond hypoxia itself, sleep apnea fragments sleep architecture, disrupting the deep, restorative stages of sleep critical for metabolic regulation. Research has consistently shown that sleep deprivation and fragmentation independently impair glucose metabolism, reduce insulin sensitivity, and increase appetite-regulating hormones like ghrelin (which drives hunger) while suppressing leptin (which signals satiety).

A study published in Sleep demonstrated that even one night of sleep restriction significantly impaired insulin sensitivity in healthy adults, an effect comparable to six months of an unhealthy diet.⁴

5. Inflammation and Oxidative Stress

Intermittent hypoxia generates significant oxidative stress and activates inflammatory pathways, including NF-κB and the production of pro-inflammatory cytokines like IL-6 and TNF-α. As discussed in previous posts, chronic inflammation directly impairs insulin signaling and drives insulin resistance, creating yet another pathway through which sleep apnea contributes to blood sugar dysregulation.⁵

The Clinical Picture: What I See in Practice

The pattern I see repeatedly in practice looks something like this:

A client comes in with an A1c of 5.8–6.4% (prediabetic range) or even higher. They eat a balanced, whole-food diet. They exercise regularly. They're not significantly overweight. By conventional standards, their diet and lifestyle look good, yet their blood sugar markers tell a different story.

When we place a CGM, the data is often revealing. Instead of the flat or rolling waves we’d see in a steady glucose curve overnight in a fasted state, we see repeated spikes, sometimes reaching 140–160 mg/dL or higher, occurring in the middle of the night. These spikes aren't explained by late-night eating. They're driven by repeated cortisol surges and hepatic glucose output triggered by apnea events.

A referral for a sleep study frequently confirms obstructive sleep apnea with significant oxygen desaturation. In many cases, CPAP therapy, which maintains positive airway pressure to keep the airway open during sleep, leads to meaningful improvements in fasting glucose and A1c, sometimes without any changes in diet or exercise.

The Research: Sleep Apnea Treatment and Blood Sugar

The evidence supporting CPAP therapy as a metabolic intervention is compelling. A meta-analysis published in the Journal of Clinical Endocrinology & Metabolism found that CPAP treatment significantly reduced fasting glucose, insulin resistance (HOMA-IR), and HbA1c in patients with both sleep apnea and type 2 diabetes.⁶

Another study published in Diabetes Care found that effective CPAP use was associated with significant reductions in nocturnal glucose excursions and improved overall glycemic control, effects that were most pronounced in patients with more severe sleep apnea.⁷

Who Should Be Screened?

Sleep apnea is significantly underdiagnosed. It is estimated that up to 80% of moderate-to-severe cases remain undiagnosed in the general population. Risk factors include:

• Nasal congestion or structural nasal issues

• Anatomical features (recessed jaw, enlarged tonsils)

• Family history

• Alcohol use (relaxes airway muscles)

• Male sex (though women are also affected, particularly post-menopause)

• Age over 40

• Large neck circumference

• Obesity (especially central adiposity)

However, and this is critical, sleep apnea can and does occur in people who are not overweight. I have seen this repeatedly in clinical practice. A lean, fit individual with a high A1c and nocturnal glucose spikes on CGM may have sleep apnea as a primary driver of their metabolic dysfunction.

Red Flags That Warrant a Sleep Study

Consider discussing a sleep study with your healthcare provider if you experience:

• Loud snoring or gasping during sleep (often reported by a partner)

• Waking unrefreshed despite adequate sleep time

• Daytime fatigue or excessive sleepiness

• Morning headaches

• Difficulty concentrating or brain fog

• Elevated A1c or fasting glucose that doesn't respond to dietary changes

• Nocturnal glucose spikes on CGM data

• Hypertension that is difficult to control

• Frequent nighttime urination

A Functional Nutrition Perspective

This is precisely why functional nutrition takes a systems-based approach to health. Blood sugar dysregulation is not always, or even primarily, a dietary problem. It can be driven by sleep disruption, chronic stress, inflammation, hormonal imbalance, mitochondrial dysfunction, toxin exposure, gut dysbiosis, and more.

When a client's A1c doesn't respond to dietary optimization, I don't simply recommend more restriction. I ask:

• How is your sleep quality and quantity?

• Do you snore or wake unrefreshed?

• What does your CGM data show overnight?

• What are your cortisol patterns?

• What is your inflammatory burden?

Addressing sleep apnea, whether through CPAP therapy, positional therapy, weight management, myofunctional therapy, or other interventions, can be one of the most powerful metabolic interventions available. And it has nothing to do with what's on your plate.

The Bottom Line

If your A1c is elevated despite a clean diet and regular exercise, sleep apnea may be the missing piece. Intermittent hypoxia drives nocturnal cortisol surges, hepatic glucose output, insulin resistance, sympathetic nervous system activation, inflammation, and circadian disruption, all of which impair blood sugar regulation independently of diet.

A CGM can be a powerful diagnostic tool for identifying nocturnal glucose spikes, and a sleep study can confirm whether sleep apnea is contributing to your metabolic dysfunction. Treatment of sleep apnea has been shown to meaningfully improve fasting glucose, insulin resistance, and A1c, sometimes dramatically.

True metabolic health requires looking at the whole person, not just the plate.

Sources:

1. Punjabi NM, Beamer BA. "Alterations in Glucose Disposal in Sleep-Disordered Breathing." American Journal of Respiratory and Critical Care Medicine. 2009. https://doi.org/10.1164/rccm.200809-1392OC

2. Punjabi NM, et al. "Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance." Diabetes Care. 2004. https://doi.org/10.2337/diacare.27.10.2464

3. Tasali E, Mokhlesi B, Van Cauter E. "Obstructive Sleep Apnea and Type 2 Diabetes: Interacting Epidemics." Chest. 2008. https://doi.org/10.1378/chest.07-0828

4. Buxton OM, et al. "Sleep Restriction for One Week Reduces Insulin Sensitivity." Sleep. 2010. https://doi.org/10.1093/sleep/33.9.1139

5. Ryan S, Taylor CT, McNicholas WT. "Selective Activation of Inflammatory Pathways by Intermittent Hypoxia in Obstructive Sleep Apnea Syndrome." Circulation. 2005. https://doi.org/10.1161/CIRCULATIONAHA.104.503557

6. Iftikhar IH, et al. "Effects of CPAP on Glycemic Control in Diabetic Patients with Sleep Apnea: A Systematic Review and Meta-Analysis." Journal of Clinical Endocrinology & Metabolism. 2013. https://doi.org/10.1210/jc.2013-2265

7. Harsch IA, et al. "Continuous Positive Airway Pressure Treatment Rapidly Improves Insulin Sensitivity in Patients with Obstructive Sleep Apnea Syndrome." Diabetes Care. 2004. https://doi.org/10.2337/diacare.27.12.2784